MedTrace Logo

Amplatzer Amulet China Post Market Study (PMS)

NCT06189365 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2025-12-18

No results posted yet for this study

Summary

The purpose of this study is to prospectively evaluate the safety and effectiveness of the Amplatzer Amulet LAA occluder in a Chinese patient population indicated for use of this device.

Conditions

  • Non-Valvular Atrial Fibrillation

Interventions

DEVICE

Left Atrial Appendage (LAA) closure procedure with Amplatzer Amulet LAA occluder

Subject will receive the Left Atrial Appendage (LAA) closure procedure with Amplatzer Amulet LAA occluder.

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Zhihui ZHANG · The Third Xiangya Hospital of Central South University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-30
Primary Completion
2025-12-05
Completion
2025-12-05
FDA Device
Yes

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06189365 on ClinicalTrials.gov